THE POSITION OF THE STRUCTURALLY AUTONOMOUS KRINGLE-2 DOMAIN INFLUENCES THE FUNCTIONAL FEATURES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR

被引:6
作者
BAKKER, AHF
REHBERG, EF
MAROTTI, KR
VERHEIJEN, JH
机构
[1] TNO PG,GAUBIUS LAB,2301 CE LEIDEN,NETHERLANDS
[2] UPJOHN CO,DEPT BIOL MOLEC,KALAMAZOO,MI 49001
来源
PROTEIN ENGINEERING | 1995年 / 8卷 / 03期
关键词
DOMAIN REVERSAL; FUNCTIONAL ANALYSIS; MUTANT; TISSUE-TYPE PLASMINOGEN ACTIVATOR;
D O I
10.1093/protein/8.3.293
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tissue-type plasminogen activator (t-PA) is composed of structurally autonomous domains, From the N-terminus of t-PA, a finger-like domain (F), an epidermal growth factor-like domain (G), two kringle domains (K1 and K2) and a serine protease domain (P) can be discerned, The K2 domain of t-PA is known to be involved in lysine binding, fibrin binding and fibrin-dependent plasminogen activation, To study the functional autonomy of the K2 domain in t-PA we constructed, with the aid of a cassette t-PA gene [Rehberg et al. (1989) Protein Engng, 2, 371-377], mutant t-PA genes coding for four molecules (FGK1K2P, FGK2K1P, GK1K2P and GK2K1P) in which the K2 domain was placed in two different positions in t-PA, The DNAs of wild-type t-PA and the t-PA variants were expressed in Chinese hamster ovary cells and the recombinant proteins were purified by affinity chromatography, All molecules were expressed in their single-chain form and could be converted to their two-chain form, With these molecules, lysine binding, fibrin binding and fibrin-dependent plasminogen activation were studied, All variants showed affinity for lysyl-Sepharose and aminohexyl-Sepharose, Reversal of the K domains (FGK2K1P versus FGK2K1P and GK1K2P versus GK2K1P) resulted in a 23-47% weaker interaction to both lysyl-Sepharose and aminohexyl-Sepharose Deleting the F domain (FGK1K2P versus GK1K2P and FGK2K1P versus GK2K1P) resulted in a 20-70% improvement of the interactions lysyl-Sepharose and aminohexyl-Sepharose. All variants bound to a forming fibrin clot, Reversal of the K domains (FGK1K2P versus FGK2K1P) reduced fibrin binding, In the presence of the lysine analogue epsilon-amino caproic acid, only FGK1K2P bound to fibrin, All variants activated plasminogen, In the absence of fibrinogen CNBr fragments (mimic of fibrin), the reversal of the K domain (FGK2K1P) resulted in a 2-fold improved plasminogen activation, In the presence of a fibrin mimic, the plasminogen activations of the F domain deletion analogues GK1K2P and GK2K1P were found to be decreased 2- to 4-fold, From these results we concluded that the function of t-PA in lysine binding, fibrin binding and fibrin-dependent plasminogen activation is dependent on the correct spatial orientation of the K2 domain within the t-PA molecule.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 39 条
[1]  
BAKKER AHF, 1993, J BIOL CHEM, V268, P18496
[2]  
BENNETT WF, 1991, J BIOL CHEM, V266, P5191
[3]  
BINDER BR, 1980, PROTIDES BIOL FLUIDS, P391
[4]   H-1-NMR STRUCTURAL CHARACTERIZATION OF A RECOMBINANT KRINGLE-2 DOMAIN FROM HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
BYEON, IJL ;
KELLEY, RF ;
LLINAS, M .
BIOCHEMISTRY, 1989, 28 (24) :9350-9360
[5]   SOLUTION STRUCTURE OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR KRINGLE-2 DOMAIN COMPLEXED TO 6-AMINOHEXANOIC ACID AN ANTIFIBRINOLYTIC DRUG [J].
BYEON, IJL ;
LLINAS, M .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 222 (04) :1035-1051
[6]  
COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77
[7]   BINDING OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR TO LYSINE, LYSINE ANALOGS, AND FIBRIN FRAGMENTS [J].
DEMUNK, GAW ;
CASPERS, MPM ;
CHANG, GTG ;
POUWELS, PH ;
ENGERVALK, BE ;
VERHEIJEN, JH .
BIOCHEMISTRY, 1989, 28 (18) :7318-7325
[8]   CRYSTAL-STRUCTURE OF THE KRINGLE-2 DOMAIN OF TISSUE PLASMINOGEN-ACTIVATOR AT 2.4-A RESOLUTION [J].
DEVOS, AM ;
ULTSCH, MH ;
KELLEY, RF ;
PADMANABHAN, K ;
TULINSKY, A ;
WESTBROOK, ML ;
KOSSIAKOFF, AA .
BIOCHEMISTRY, 1992, 31 (01) :270-279
[9]  
FRIEZNERDEGEN SJ, 1986, J BIOL CHEM, V261, P6972
[10]   STUDY OF PROTEASES AND PROTEASE-INHIBITOR COMPLEXES IN BIOLOGICAL-FLUIDS [J].
GRANELLIPIPERNO, A ;
REICH, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (01) :223-234